Host defenses at mucosal surfaces

Clinical Immunology

Volumn , Issue , 2008, Pages 287-303

  Fujihashi, Kohtaro ^a   Boyaka, Prosper N ^b   McGhee, Jerry R ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882911948     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04404-2.10019-3     Document Type: Chapter

References (53)

1. Mestecky J., Blumberg R.S., Kiyono H., McGhee J.R. The mucosal immune system. Fundamental immunology 2003, 965. Lippincott Williams & Wilkins, Philadelphia. W.E. Paul (Ed.).
2. Porter E.M., Liu L., Oren A., et al. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 1997, 65:2389.
3. Kato T., Owen R. Structure and function of intestinal mucosal epithelium. Mucosal immunology, 3rd ed Vol. 1 2005, 131. Elsevier Academic Press, Burlington. J. Mestecky, M.E. Lamm, W. Strober (Eds.).
4. Kiyono H., Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nature Rev Immunol 2004, 4:699.
5. Fu Y.X., Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999, 17:399.
6. Lorenz R.G., Chaplin D.D., McDonald K.G., et al. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol 2003, 170:5475.
7. Quiding-Jarbrink M., Granstrom G., Nordstrom I., et al. Induction of compartmentalized B-cell responses in human tonsils. Infect Immun 1995, 63:853.
8. Lehner T., Brookes R., Panagiotidi C., et al. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci USA 1993, 90:8638.
9. Forrest B.D., Shearman D.J., LaBrooy J.T. Specific immune response in humans following rectal delivery of live typhoid vaccine. Vaccine 1990, 8:209.
10. Youngman K.R., Lazarus N.H., Butcher E. Lymphocyte homing: Chemokines and adhesion molecules in T cell and IgA plasma cell localization in the mucosal immune system. Mucosal immunology, 3rd ed. Vol. 1 2005, 667. Elsevier Academic Press. J. Mestecky, M.E. Lamm, W. Strober (Eds.).
11. Holzmann B., McIntyre B.W., Weissman I.L. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an a chain homologous to human VLA-4 alpha. Cell 1989, 56:37.
12. Quiding M., Nordstrom I., Kilander A., et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest 1991, 88:143.
13. Quiding-Jarbrink M., Lakew M., Nordstrom I., et al. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol 1995, 25:322.
14. Csencsits K.L., Jutila M.A., Pascual D.W. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site. J Immunol 1999, 163:1382.
15. Wolber F.M., Curtis J.L., Milik A.M., et al. Lymphocyte recruitment and the kinetics of adhesion receptor expression during the pulmonary immune response to particulate antigen. Am J Pathol 1997, 151:1715.
16. Quiding-Jarbrink M., Nordstrom I., Granstrom G., et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997, 99:1281.
17. Kelsall B.L., Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996, 183:237.
18. Widhe M., Ekerfelt C., Forsberg P., et al. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand J Immunol 1998, 47:575.
19. Austrup F., Vestweber D., Borges E., et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997, 385:81.
20. Fujihashi K., McGhee J.R., Lue C., et al. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest 1991, 88:248.
21. Fujihashi K., McGhee J.R. Th1/Th2/Th3 cells for regulation of mucosal immunity, tolerance and inflammation. Mucosal Immunology, 3rd ed. vol.1 2005, 539. Elsevier, Academic Press, Burlington, MA. J. Mestecky, M.E. Lamm, W. Strober (Eds.).
22. Yamamoto S., Kiyono H., Yamamoto M., et al. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 1997, 94:5267.
23. Rappuoli R., Pizza M., Douce G., Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 1999, 20:493.
24. Mancini P., Santi P.A. Localization of the GM1 ganglioside in the vestibular system using cholera toxin. Hear Res 1993, 64:151.
25. van Ginkel F.W., Jackson R.J., Yuki Y., McGhee J.R. The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 2000, 165:4778.
26. Yoshino N., Lu F.X., Fujihashi K., et al. A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates. J Immunol 2004, 173:6850.
27. Agren L., Lowenadler B., Lycke N. A novel concept in mucosal adjuvanticity: the CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit. Immunol Cell Biol 1998, 76:280.
28. Eriksson A.M., Schon K.M., Lycke N.Y. The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues. J Immunol 2004, 173:3310.
29. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 1998, 19:89.
30. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 1998, 16:1216.
31. Boyaka P.N., Marinaro M., Jackson R.J., et al. IL-12 is an effective adjuvant for induction of mucosal immunity. J Immunol 1999, 162:122.
32. Williamson E., Westrich G.M., Viney J.L. Modulating dendritic cells to optimize mucosal immunization protocols. J Immunol 1999, 163:3668.
33. + dendritic cells for enhanced mucosal immunity. J Immunol 2004, 172:3612.
34. Haq T.A., Mason H.S., Clements J.D., Arntzen C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995, 268:714.
35. Tacket C.O., Mason H.S., Losonsky G., et al. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med 1998, 4:607.
36. Takagi H., Hiroi T., Yang L., et al. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA 2005, 102:17525.
37. Mestecky J., Moro I., Kerr M.A., Woof J.M. Mucosal immunoglobulins. Mucosal Immunology, 3rd ed. Vol. 1 2005, 153. Elsevier Academic Press, Burlington. J. Mestecky, M.E. Lamm, J. Bienenstock (Eds.).
38. Kauppi-Korkeila M., van Alphen L., Madore D., et al. Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. J Infect Dis 1996, 174:1337.
39. Burrows P.D., Cooper M.D. IgA deficiency. Adv Immunol 1997, 65:245.
40. Neutra M.R., Kreahenbuhl J.P. Cellular and molecular basis for antigen transport accross epithelial barriers. Mucosal Immunology, 3rd ed, Vol. 1 2005, 111. Elsevier Academic Press, Burlington. J. Mestecky, M.E. Lamm, J. Bienenstock (Eds.).
41. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996, 272:104.
42. Cuff C.F., Cebra C.K., Rubin D.H., Cebra J.J. Developmental relationship between cytotoxic α/β T cell receptor-positive intraepithelial lymphocytes and Peyer's patch lymphocytes. Eur J Immunol 1993, 23:1333.
43. + T cells. J Immunol 1990, 144:3980.
44. + T cells. J Exp Med 1990, 172:1225.
45. Graham B.S., Henderson G.S., Tang Y.W., et al. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993, 151:2032.
46. Miller C.J., McChesney M.B., Lu X., et al. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 1911, 1997:71.
47. Kiyono H., McGhee J.R. Mucosal immunology: intraepithelial lymphocytes 1994, Raven Press, New York.
48. Fujihashi K., Ernst P.B. A mucosal internet: Epithelial cell-immune cell interactions. Mucosal Immunology 1998, 619. Academic Press, San Diego, CA. P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee (Eds.).
49. Challacombe S.J., Tomasi T.B. Systemic tolerance and secretory immunity after oral immunization. J Exp Med 1980, 152:1459.
50. Mowat A.M., Faria A.M.C., Weiner H.L. Oral tolerance: physiological basis and clinical applications. Mucosal Immunology, 3rd ed. Vol.1 2005, 487. Elsevier Academic press, Burlington, MA. J. Mestecky, M.E. Lamm, W. Strober (Eds.).
51. + versus acquired Tr1 and Th3 regulatory T cells. Transplantation 2004, 77:S12.
52. Miller R.A. The aging immune system: primer and prospectus. Science 1996, 273:70.
53. Fujihashi K., McGhee J.R. Mucosal immunity and tolerance in the elderly. Mech Aging Dev 2004, 125:889.